当前位置: 首页 > 期刊 > 《健康必读·下旬刊》 > 20207
编号:13471406
生物制剂治疗风湿免疫病的临床疗效
http://www.100md.com 2020年7月1日 《健康必读·下旬刊》 20207
     【摘 要】:目的:就生物制剂治疗风湿免疫病的临床疗效进行研究、分析。方法:抽取我院近两年内收治的风湿免疫病患者,对其实施生物制剂治疗。结果:患者接受生物制剂治疗后,其治疗总有效率呈良好状态,临床症状改善明显。结论:在风湿免疫病的治疗中,生物制剂发挥的作用明显。

    【关键词】:生物制剂;风湿免疫病;临床疗效

    Abstract: objective: to study and analyze the clinical efficacy of biological agents in the treatment of rheumatism and immunity. Methods: the patients with rheumatism and immunity disease were selected and treated in our hospital in the past two years. Results: after the biologic treatment, the total effective rate was good and the clinical symptoms were improved obviously. Conclusion: biological agents play an important role in the treatment of rheumatic immunity.

    Key words: biological preparation; Rheumatic immune disease; Clinical curative effect

    【中图分类号】R593.2 【文献标识码】B 【文章编号】1672-3783(2020)07-21--02

    1 资料与方法

    (1)一般资料

    本次入选人员均选自2019年1月至2020年2月我院收治的风湿免疫病患者(70例) ......

您现在查看是摘要页,全文长 5759 字符